How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Refractive Surgery Market
- By Surgery Type: LASIK (Laser-Assisted In Situ Keratomileusis), PRK (Photorefractive Keratectomy), SMILE (Small Incision Lenticule Extraction), LASEK (Laser Epithelial Keratomileusis), RK (Radial Keratotomy)
- By Technology Used: Excimer Laser, Femtosecond Laser, Wavefront-Guided Laser, Topography-Guided Laser, IntraLase Technology
- By Indication: Myopia Correction, Hyperopia Correction, Astigmatism Correction, Presbyopia Treatment
- By End User: Hospitals, Specialty Eye Clinics, Ambulatory Surgical Centers, Ophthalmology Clinics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - LASIK (Laser-Assisted In Situ Keratomileusis) leads By Surgery Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Refractive Surgery Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Surgery Type 5
Technology Used 5
Indication 4
End User 4
Companies profiled
Johnson & Johnson Vision (including AcuFocus)
Alcon (a Novartis company)
Bausch + Lomb (a division of Bausch Health Companies)
Carl Zeiss Meditec AG
Lumenis Ltd.
NIDEK Co. Ltd.
STAAR Surgical Company
Hoya Corporation (including its medical optics division)
Ziemer Ophthalmic Systems AG
Ellex Medical Lasers Ltd.
Moria Surgical
Schwind eye-tech-solutions GmbH & Co. KG
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Johnson & Johnson Vision (including AcuFocus)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Alcon (a Novartis company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bausch + Lomb (a division of Bausch Health Companies)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Carl Zeiss Meditec AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Lumenis Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →NIDEK Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →STAAR Surgical Company
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Hoya Corporation (including its medical optics division)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Ziemer Ophthalmic Systems AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Ellex Medical Lasers Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Moria Surgical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Schwind eye-tech-solutions GmbH & Co. KG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Asclepion Laser Technologies GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Rayner Intraocular Lenses Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →PhysIOL
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,583M by 2033 · 7.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- LASIK (Laser-Assisted In Situ Keratomileusis)48.7
- PRK (Photorefractive Keratectomy)12.4
- SMILE (Small Incision Lenticule Extraction)14.8
- LASEK (Laser Epithelial Keratomileusis)12.7
- RK (Radial Keratotomy)11.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,205M → $2,134M · 7.4%
Europe$839.6M → $1,401M · 6.6%
Asia Pacific$766.6M → $1,248M · 6.3%
Latin America$474.5M → $846.2M · 7.5%
Middle East and Africa$365.0M → $625.2M · 7.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.612026
7.612027
7.632028
7.642029
7.652030
7.662031
7.682032
7.692033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Johnson & Johnson Vision (including AcuFocus)15.6
- Alcon (a Novartis company)25.5
- Bausch + Lomb (a division of Bausch Health Companies)9.7
- Carl Zeiss Meditec AG8.7
- Lumenis Ltd.7.7
- NIDEK Co. Ltd.4.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgery Type29.6%
Technology Used22.3%
Indication23.6%
End User24.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.1
- Europe22.4
- Asia Pacific20.0
- Latin America13.5
- Middle East and Africa10.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson Vision (including AcuFocus) | 76 | 88 | 85 | 73 | 93 | 81 | 83 |
| Alcon (a Novartis company) | 83 | 81 | 84 | 78 | 70 | 89 | 81 |
| Bausch + Lomb (a division of Bausch Health Companies) | 80 | 75 | 86 | 81 | 75 | 74 | 79 |
| Carl Zeiss Meditec AG | 79 | 80 | 68 | 62 | 72 | 79 | 73 |
| Lumenis Ltd. | 64 | 56 | 77 | 63 | 58 | 75 | 66 |
| NIDEK Co. Ltd. | 57 | 68 | 64 | 49 | 47 | 59 | 57 |
| STAAR Surgical Company | 51 | 45 | 65 | 62 | 62 | 44 | 55 |
| Hoya Corporation (including its medical optics division) | 38 | 56 | 42 | 36 | 53 | 49 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Johnson & Johnson Vision (including AcuFocus)
- Alcon (a Novartis company)
- Bausch + Lomb (a division of Bausch Health Companies)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Johnson & Johnson Vision (including AcuFocus) | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Alcon (a Novartis company) | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Bausch + Lomb (a division of Bausch Health Companies) | ✓ | ◐ | ◐ | ✓ | ✓ | − |
| Carl Zeiss Meditec AG | ◐ | ✓ | ◐ | − | ✓ | ◐ |
| Lumenis Ltd. | ◐ | − | ◐ | ◐ | − | ✓ |
| NIDEK Co. Ltd. | ◐ | ◐ | ◐ | ◐ | − | − |
| STAAR Surgical Company | − | ◐ | ◐ | − | − | − |
| Hoya Corporation (including its medical optics division) | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Johnson & Johnson Vision (including AcuFocus)83
2Alcon (a Novartis company)81
3Bausch + Lomb (a division of Bausch Health Companies)79
4Carl Zeiss Meditec AG73
5Lumenis Ltd.66
6NIDEK Co. Ltd.57
7STAAR Surgical Company55
8Hoya Corporation (including its medical optics division)46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Johnson & Johnson Vision (including AcuFocus)Alcon (a Novartis company)Bausch + Lomb (a division of Bausch Health Companies)
Challenger1
Strong scale, closing on the leaders.
Carl Zeiss Meditec AG
Contender2
Focused players with pockets of strength.
Lumenis Ltd.NIDEK Co. Ltd.
Niche2
Specialists in a single segment or region.
STAAR Surgical CompanyHoya Corporation (including its medical optics division)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgery Type in North America, then scale across Refractive Surgery Market — a $308M beachhead inside a $4.44B market.
Beachhead (SOM)$308Mobtainable near-term
Serviceable (SAM)$1.71Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
LASIK (Laser-Assisted In Situ Keratomileusis)
Best fit — highest urgency & budget in Surgery Type.
Economic buyer79 fit
PRK (Photorefractive Keratectomy)
Strong fit — clear ROI and a fast path to value.
End user68 fit
SMILE (Small Incision Lenticule Extraction)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgery Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology Used & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Indication
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve19%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Surgery Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Refractive Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified22%
Evaluation14%
Closed-won7%
$14.0KCAC
$64KLTV
4.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Refractive Surgery Market is a resilient opportunity — $4.33B by 2033, compounding at 4.1%.
TAM · 2025$3.15Btoday
TAM · 2033$4.33Bforecast
CAGR4.1%2027–2033
Cumulative$33.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.33BTotal addressable market
SAM$1.79BServiceable available market
SOM$338MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.1% CAGR
Demand compounds through 2033, outpacing GDP across Surgery Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgery Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.33BLarge & growingTAM by 2033 at 4.1% CAGR
$1.79BServiceable nowreachable with today’s model
$338MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.37BBear2.6% CAGR
$4.33BBase4.1% CAGR
$5.54BBull5.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology Used optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Refractive Surgery Market — a $8.77B market by 2033. Plan: grow share from 10.1% to 16.1%.
Market size · 2033$8.77Btotal addressable
Market CAGR5.9%2027–2033
Target share16.1%from 10.1% today
Revenue ambition$1.41Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.1% | 16.1% | Ahead |
| Revenue | $895M | $1.41B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 28.7% | 44.9% | On track |
| Customer retention | 89.7% | 94.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgery Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology Used capability
A defensible second engine — invest in Technology Used to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgery Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology Used
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $165M capacity & capability investment
- Greenlight bolt-on M&A in Technology Used
- Authorise North America expansion plan
- Fund R&D program for Surgery Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Refractive Surgery Market conversation — a $10.4B market you can size, segment and defend in minutes.
Market size · 2033$10.4Btotal opportunity
Growth8.2%CAGR to 2033
Addressable buyers1,511+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgery Type
Goal Grow share in Surgery Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 2 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Johnson & Johnson Vision (including AcuFocus)Alcon (a Novartis company)Bausch + Lomb (a division of Bausch Health Companies)Carl Zeiss Meditec AGLumenis Ltd.NIDEK Co. Ltd.STAAR Surgical CompanyHoya Corporation (including its medical optics division)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Refractive Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Refractive Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Refractive Solutions Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportRefractive Multifocal Intraocular Lens Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportRefractive Laser System Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportRefractive Instrument Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportRefractive Index Measurement Services Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportRefractive Index Liquid Chromatography Detectors Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportRefractive Analyzer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportRefraction Sugar Meter Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportReflux Monitoring System Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportReflective Microscope Objectives Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportRe-Entry Catheter Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportReefer Container for Pharmaceutical Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.